Amgen in $1.9bn swoop for Five Prime and its gastric cancer drug

8d ago, source: pharmaphorum

Amgen is to buy US biotech Five Prime Therapeutics for around $1.9 billion, adding a potential gastric cancer drug to its pipeline. The big pharma swooped in after the California biotech reported ...

If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today

on MSN ago, source:

Here's the answer: From your initial $1,000 investment, you'd now have $1,324. If that looks pretty good to you, it shouldn't ...

PFIZER INC's Net Worth

12d ago, source: Benzinga.com

Flexion Therapeutics Inc, Celladon Corp, Zoetis Inc., ICAGEN INC, ENCYSIVE PHARMACEUTICALS INC, ARQULE INC, FIVE PRIME THERAPEUTICS INC, KING PHARMACEUTICALS INC, Coley Pharmaceutical Group ...

PAC Profile: Prime Therapeutics

12d ago, source: OpenSecrets.org

*Based on data released by the Federal Election Commission on April 22, 2024 except for independent expenditure and communication cost, contributions to federal candidates, and contributions from ...

Global Peptide Therapeutics Industry

2d ago, source: Future Market Insights

Global Peptide Therapeutics Industry is valued at US$ 38.0 Bn for 2023 & expected to reach US$ 106.0 Bn by 2033 at a CAGR of ...

Aileron Therapeutics Inc ALRN

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

OTLK Outlook Therapeutics, Inc.

1d ago, source: Seeking Alpha

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead ...

TARA Protara Therapeutics, Inc.

2d ago, source: Seeking Alpha

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company’s lead program is ...

Intellia Therapeutics Inc NTLA

2d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Codexis, Inc. (NASDAQ:CDXS) Q1 2024 Earnings Call Transcript

on MSN ago, source:

Q1 2024 Earnings Call Transcript May 2, 2024 Codexis, Inc. beats earnings expectations. Reported EPS is $-0.1647, ...

Akero Therapeutics, Inc.

2mon ago, source: CNN

Akero Therapeutics, Inc. is a clinical-stage company, which engages in the development of treatments for patients with serious metabolic diseases. The firm's lead product candidate, efruxifermin ...